GI
IMCR icon

GAMMA Investing’s Immunocore IMCR Stock Holding History

GAMMA Investing’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Buy
1,920
+1,286
+203% +$38K ﹤0.01% 2166
2026
Q1 		$19.1K Sell
634
-242
-28% -$7.83K ﹤0.01% 2738
2025
Q4 		$30.4K Sell
876
-38
-4% -$1.34K ﹤0.01% 2384
2025
Q3 		$33.2K Buy
914
+311
+52% +$10.6K ﹤0.01% 2247
2025
Q2 		$18.9K Sell
603
-41
-6% -$1.27K ﹤0.01% 2485
2025
Q1 		$19.1K Buy
644
+85
+15% +$2.55K ﹤0.01% 2407
2024
Q4 		$16.5K Buy
559
+136
+32% +$4.3K ﹤0.01% 2367
2024
Q3 		$13.2K Buy
423
+265
+168% +$9.64K ﹤0.01% 2334
2024
Q2 		$5.36K Buy
158
+22
+16% +$1.12K ﹤0.01% 2548
2024
Q1 		$8.84K Buy
136
+97
+249% +$6.66K ﹤0.01% 2128
2023
Q4 		$2.82K Buy
+39
New +$2.03K ﹤0.01% 2468

Other funds holding IMCR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's IMCR Position: Q2 2026 in Review

GAMMA Investing increased its Immunocore (IMCR) stake by 203% in Q2 2026, buying an estimated $38K and bringing the position to 1,920 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

GAMMA Investing first reported a position in IMCR in Q4 2023 and has held it in 11 quarters since. 13 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • GAMMA Investing held 1,920 shares of Immunocore worth $61K as of Q2 2026.
  • GAMMA Investing bought 1,286 Immunocore shares in Q2 2026, an estimated $38K.
  • Immunocore made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2166 holding.
  • GAMMA Investing first reported a position in Immunocore in Q4 2023 and has held it in 11 quarters since.
  • 13 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.